Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer02:18

Cancer

48.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
What is Cancer?02:12

What is Cancer?

10.7K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Bidirectional coupling among EMT, AXL-RB1 signaling and lineage switch drives resistance to osimertinib and worse clinical outcomes in NSCLC.

bioRxiv : the preprint server for biology·2026
Same author

Emerging trends and treatment strategies in ovarian cancer: A comprehensive review.

Critical reviews in oncology/hematology·2026
Same author

RLIP depletion suppresses ovarian cancer growth and metastasis.

Journal of ovarian research·2026
Same author

Machine Learning Models for Predicting Gynecological Cancers: Advances, Challenges, and Future Directions.

Cancers·2025
Same author

Cancer Immunotherapy-An Overview.

Cancer treatment and research·2025
Same author

Phenotypic Plasticity, Non-genetic Mechanisms, and Immune Drug Resistance in Cancer.

Cancer treatment and research·2025

相关实验视频

Updated: Jul 1, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.4K

了解癌症和进化中的表型可塑性.

Prakash Kulkarni1,2,3, Ravi Salgia1

  • 1Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA.

iScience
|March 14, 2024
PubMed
概括

现型可塑性允许生物和癌细胞适应环境变化. 了解这种特征可以让我们了解进化和新的癌症治疗方法.

科学领域:

  • 进化生物学是进化的生物学.
  • 癌症生物学 癌症生物学
  • 遗传学 遗传学 是一个

背景情况:

  • 生物和癌细胞表现出表型可塑性,将其特征适应环境条件.
  • 现型可塑性是一种定量特征,通过将现型与环境环境结合起来,增强了生物体的健康状况.

研究的目的:

  • 探索表型可塑性在癌症和进化中的关键作用.
  • 研究表型可塑性的潜在机制.
  • 确定癌症治疗的潜在新型治疗策略.

主要方法:

  • 这项研究综合了关于表型可塑性的新兴证据.
  • 它回顾了当前关于其在进化和癌症中的作用的研究.
  • 基于现有文献,讨论了机械学的见解.

主要成果:

  • 现型可塑性对于在自然选择和癌症进展中适应至关重要.
  • 它挑战了新的特征仅仅来自遗传因素的概念.
  • 这项研究强调了塑性对进化新性的贡献.

结论:

  • 了解表型可塑性机制可以阐明生物的进化和新奇的起源.

更多相关视频

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.4K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

791

相关实验视频

Last Updated: Jul 1, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.4K
Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.4K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

791
  • 这些知识可以带来创新的癌症治疗方法的开发.
  • 针对表型可塑性可能为癌症治疗提供新的途径.